sumatriptan

(redirected from Imitrex STATdose)
Also found in: Dictionary.

Related to Imitrex STATdose: Sumatriptan succinate, Alsuma

sumatriptan

[soo″mah-trip´tan]

a selective serotonin receptor agonist used as the succinate salt in the acute treatment of migraine and cluster headaches; administered orally, subcutaneously, or intranasally.

sumatriptan

/su·ma·trip·tan/ (soo″mah-trip´tan) a selective serotonin receptor agonist used as the succinate salt in the acute treatment of migraine and cluster headaches.

sumatriptan

(so͞o′mə-trĭp′tn)

A triptan drug, C₁₄H₂₁N₃O₂S, used also in the form of its succinate to treat migraine headache and cluster headache.

sumatriptan

A SEROTONIN antagonist drug that has been found effective in the symptomatic treatment of acute MIGRAINE. A brand name is Imigran.

References in periodicals archive ?

Imitrex Injection is available in the easy-to-use Imitrex STATdose System, which allows patients to conveniently administer a 4mg dose of Imitrex with just the push of a button.

The Imitrex STATdose System includes two small, disposable cartridges pre-filled with a single dose of Imitrex, and an easy to use autoinjector pen that allows patients to self-administer the medication about one-quarter inch under the skin.

According to a study published in Headache, 88 percent of patients found the Imitrex STATdose System easy to use.

FDA Approves New Formulation of Imitrex(R) (Sumatriptan Succinate) Injection

In addition, Allergan has obtained the right to co-promote GSK's products IMITREX STATdose System(R) and AMERGE(R) in the U.

Second, the co-promotion of GSK's IMITREX STATdose System(R) and AMERGE(R) in the U.

IMITREX STATdose System(R) is approved for the acute treatment of migraine with and without aura and for the treatment of cluster headaches in adults.

Allergan Enters Into Agreement with GlaxoSmithKline to Accelerate BOTOX(R) Development and Commercialization in Japan and China, Co-Promote IMITREX STATdose System(R) and AMERGE(R) in U.S